☆ 4.6 Review

Evolving treatment paradigms for PCV

EYE (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Ophthalmology

Efficacy of a novel personalised aflibercept monotherapy regimen based on polypoidal lesion closure in participants with polypoidal choroidal vasculopathy

Kelvin Yi Chong Teo et al.

Summary: The personalised regimen was non-inferior to the fixed regimen in terms of BCVA improvement, and showed numerically higher closure of PL. Further results also demonstrated that the personalised group had a greater reduction in CSFT compared to the fixed group.

BRITISH JOURNAL OF OPHTHALMOLOGY (2022)

添加到收藏夹

Article Ophthalmology

Timing of Complete Polypoidal Regression after Intravitreous Aflibercept Treatments in Polypoidal Choroidal Vasculopathy

Voraporn Chaikitmongkol et al.

Summary: This multicenter prospective study aimed to understand the timing of complete polypoidal regression on indocyanine green angiography (ICGA) after aflibercept injections for polypoidal choroidal vasculopathy (PCV). The results showed that complete polypoidal regression could occur as early as 2 months after aflibercept injections, and most PCV eyes with complete polypoidal regression at 1 year already showed complete regression within the first 6 months.

OPHTHALMOLOGY RETINA (2022)

添加到收藏夹

Letter Ophthalmology

Prevalence of polypoidal choroidal vasculopathy in Caucasian patients as estimated from optical coherence tomography signs

Gerald Liew et al.

EYE (2021)

添加到收藏夹

Review Ophthalmology

Influence of pigment epithelial detachment on visual acuity in neovascular age-related macular degeneration

Kai Xiong Cheong et al.

Summary: The influence of PED on visual acuity is controversial, with some studies showing PED may still be compatible with relatively good visual acuity. However, there is currently no strong evidence that the presence of PED or aspects of its morphology significantly impact visual acuity. More well-designed studies are needed to evaluate the relationship between PED and visual acuity.

SURVEY OF OPHTHALMOLOGY (2021)

添加到收藏夹

Article Ophthalmology

RANIBIZUMAB WITH OR WITHOUT VERTEPORFIN PHOTODYNAMIC THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHY Predictors of Visual and Anatomical Response in the EVEREST II Study

Chui Ming Gemmy Cheung et al.

Summary: Several imaging parameters at baseline and M3 can predict treatment outcome. The interaction between treatment arm and total polypoidal lesion area suggests this feature may assist selecting between initial ranibizumab monotherapy or combination therapy.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2021)

添加到收藏夹

Article Ophthalmology

POLYPOIDAL CHOROIDAL VASCULOPATHY FEATURES VARY ACCORDING TO SUBFOVEAL CHOROIDAL THICKNESS

Janice Marie Jordan-Yu et al.

Summary: This study found that in PCV lesions, there is a significant linear increase in total lesion area and polypoidal lesion area with increasing subfoveal choroidal thickness.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2021)

添加到收藏夹

Article Ophthalmology

Massive submacular haemorrhage in polypoidal choroidal vasculopathy versus typical neovascular age-related macular degeneration

Soo Chang Cho et al.

Summary: The study found that the incidence rate of massive submacular haemorrhage was significantly higher in patients with polypoidal choroidal vasculopathy compared to those with typical neovascular age-related macular degeneration. The number of photodynamic therapies, cluster type of polypoidal lesion, and number of anti-VEGF injections were significantly associated with the risk of massive submacular haemorrhage.

ACTA OPHTHALMOLOGICA (2021)

添加到收藏夹

Article Ophthalmology

Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD

Usha Chakravarthy et al.

Summary: The study reveals that greater fluctuations in retinal fluid volumes during the maintenance phase of anti-VEGF treatment in nAMD are associated with worse visual acuity by 2 years.

EYE (2021)

添加到收藏夹

Review Ophthalmology

THE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES A Review

Jeffrey S. Heier et al.

Summary: This review aims to provide ophthalmologists and practicing retina specialists with an overview of clinical evidence and therapeutic potential of targeting the angiopoietin/Tie pathway in retinal vascular diseases. Literature search and clinical trials suggest that drugs targeting this pathway may have potential benefits in treating retinal vascular diseases due to the synergistic nature of the pathways involved.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2021)

添加到收藏夹

Review Ophthalmology

Angiopoietin/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data

Antonia M. Joussen et al.

Summary: The Ang/Tie pathway is an emerging key regulator in vascular development and inflammation, playing important roles in regulating vascular stability and potentially serving as a therapeutic target for vascular stability and inflammation.

EYE (2021)

添加到收藏夹

Article Medicine, General & Internal

Five-Year Outcome of Aflibercept Monotherapy for Exudative Age-Related Macular Degeneration with Good Baseline Visual Acuity

Wataru Kikushima et al.

Summary: Aflibercept monotherapy shows initial improvement in visual acuity for exudative AMD patients with good baseline BCVA, but the effect diminishes after two years, with similar final BCVA levels observed after five years. Retreatment was required for the majority of patients during the study period.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Cell Biology

Untargeted metabolomics for uncovering plasma biological markers of wet age-related macular degeneration

Yanhui Deng et al.

Aging-US (2021)

添加到收藏夹

Article Ophthalmology

Automated Quantitative Assessment of Retinal Fluid Volumes as Important Biomarkers in Degeneration

Tiarnan D. L. Keenan et al.

Summary: The study evaluated the use of artificial intelligence algorithms to extract retinal fluid volume data from OCT scans for treatment of NVAMD. The results showed rapid decrease in fluid volumes with anti-VEGF therapy, and the importance of quantitative measures of IRF, SRF, and PED as biomarkers in NV-AMD. Using nanoliters as a convenient unit for consistency between studies is proposed.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)

添加到收藏夹

Article Ophthalmology

Association between retinal thickness variation and visual acuity change in neovascular age-related macular degeneration

Kai Xiong Cheong et al.

Summary: The study found that greater variation in retinal thickness during VEGF inhibitor therapy for nAMD is associated with a less favorable visual outcome. CSFT stability is useful in prognosticating visual outcomes in VEGF inhibitor therapy for nAMD.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2021)

添加到收藏夹

Article Ophthalmology

One year outcomes of treat and extend and pro re nata (PRN) treatment regimens with aflibercept for polypoidal choroidal vasculopathy

Alexandros Rouvas et al.

Summary: The study found that the treat-and-extend regimen with aflibercept was superior to PRN treatment for patients with PCV, showing significant improvements in visual acuity and prevention of recurrence, despite requiring more injections.

EUROPEAN JOURNAL OF OPHTHALMOLOGY (2021)

添加到收藏夹

Article Ophthalmology

PULSATILE FILLING OF DILATED CHOROIDAL VESSELS IN MACULAR WATERSHED ZONES

Chui Ming Gemmy Cheung et al.

Summary: This study observed pulsatile filling of dilated choroidal veins in patients with exudative retinal diseases, with variations in pressure gradients in the affected veins. The dilated segments may lead to pooling of venous blood, which may play a role in these diseases.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2021)

添加到收藏夹

Article Ophthalmology

INTERVORTEX VENOUS ANASTOMOSIS IN Pachychoroid-RELATED DISORDERS

Richard F. Spaide et al.

Summary: The study evaluated choroidal vascular patterns of patients with pachychoroid-related diseases in wide-field indocyanine green angiography images. The findings revealed variations in venous anastomoses between vortex vein systems among different diseases.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Short-term outcomes of intravitreal brolucizumab for treatment-naive neovascular age-related macular degeneration with type 1 choroidal neovascularization including polypoidal choroidal vasculopathy

Hidetaka Matsumoto et al.

Summary: Loading phase treatment with intravitreal brolucizumab may improve visual acuity and reduce exudative changes in eyes with nAMD associated with type 1 CNV, but careful monitoring for brolucizumab-related intraocular inflammation is necessary.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Ophthalmology

Comparison of Central Macular Fluid Volume With Central Subfield Thickness in Patients With Diabetic Macular Edema Using Optical Coherence Tomography Angiography

Qi Sheng You et al.

Summary: The study found that automated CMFV is a more accurate diagnostic biomarker than CST for diabetic macular edema, potentially improving the screening for this condition.

JAMA OPHTHALMOLOGY (2021)

添加到收藏夹

Article Ophthalmology

Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan

Gregg T. Kokame et al.

Summary: This study aims to differentiate clinical features between eyes diagnosed with PCV and typical AMD, finding that PCV eyes have a higher prevalence of SRF but similar rates of other factors like macular edema, SHRM, and RPED compared to AMD eyes. Additionally, the presence of visible polypoidal lesions in PCV eyes decreased after treatment.

OPHTHALMOLOGY RETINA (2021)

添加到收藏夹

Article Ophthalmology

Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2

Kelvin Yi Chong Teo et al.

Summary: In eyes with persistent activity, a combination of non-ICGA-based criteria showed good agreement with ICGA in differentiating PCV from nAMD, with an accuracy of 0.77 in validation. OCT-guided PDT treatment spot covered 100% of PLs and 90% of the BNN, offering a potential option for adjunct PDT treatment in nAMD eyes.

OPHTHALMOLOGY RETINA (2021)

添加到收藏夹

Article Ophthalmology

HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration

Pravin U. Dugel et al.

OPHTHALMOLOGY (2020)

添加到收藏夹

Article Ophthalmology

DIFFERENCE BETWEEN PACHYCHOROID AND NONPACHYCHOROID POLYPOIDAL CHOROIDAL VASCULOPATHY AND THEIR RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY

Yun-Chia Chang et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2020)

添加到收藏夹

Article Ophthalmology

Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two Regions

Mark Gillies et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2020)

添加到收藏夹

Article Ophthalmology

Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group

Richard F. Spaide et al.

OPHTHALMOLOGY (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in Exudative Age-Related Macular Degeneration: 52-and 96-Week Findings from ALTAIR A Randomized Controlled Trial

Masahito Ohji et al.

ADVANCES IN THERAPY (2020)

添加到收藏夹

Article Ophthalmology

Ten-year outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular disease: A single-centre French study

Benjamin Wolff et al.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2020)

添加到收藏夹

Article Ophthalmology

The relationship between pigment epithelial detachment and visual outcome in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy

Kai Xiong Cheong et al.

EYE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy

Kikushima Wataru et al.

PLOS ONE (2020)

添加到收藏夹

Article Ophthalmology

PREVALENCE AND RISK FACTORS FOR THE DEVELOPMENT OF PHYSICIAN-GRADED SUBRETINAL FIBROSIS IN EYES TREATED FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Kelvin Yi Chong Teo et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy

Irene Tom et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Association between pachychoroid and long-term treatment outcomes of photodynamic therapy with intravitreal ranibizumab for polypoidal choroidal vasculopathy

Keiko Azuma et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Article Ophthalmology

Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab

Caroline R. Baumal et al.

OPHTHALMOLOGY (2020)

添加到收藏夹

Article Ophthalmology

Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy The EVEREST II Randomized Clinical Trial

Tock H. Lim et al.

JAMA OPHTHALMOLOGY (2020)

添加到收藏夹

Article Ophthalmology

HAWK and HARRIER

Pravin U. Dugel et al.

OPHTHALMOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Fibrovascular pigment epithelial detachment in eyes with subretinal hemorrhage secondary to neovascular AMD or PCV: a morphologic predictor associated with poor treatment outcomes

Jae Hui Kim et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Article Ophthalmology

Associations of Variation in Retinal Thickness With Visual Acuity and Anatomic Outcomes in Eyes With Neovascular Age-Related Macular Degeneration Lesions Treated With Anti-Vascular Endothelial Growth Factor Agents

Rebecca N. Evans et al.

JAMA OPHTHALMOLOGY (2020)

添加到收藏夹

Article Ophthalmology

One-Year Results of a Treat-and-Extend Regimen of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy

Tomoko Tamachi et al.

OPHTHALMOLOGY AND THERAPY (2020)

添加到收藏夹

Article Ophthalmology

Real-World Treatment Outcomes of Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Asians

Beau J. Fenner et al.

OPHTHALMOLOGY RETINA (2020)

添加到收藏夹

Review Ophthalmology

Pachychoroid disease

Chui Ming Gemmy Cheung et al.

EYE (2019)

添加到收藏夹

Article Ophthalmology

The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration Results from the Randomized Phase 2 Ladder Clinical Trial

Peter A. Campochiaro et al.

OPHTHALMOLOGY (2019)

添加到收藏夹

Article Ophthalmology

Appearance of Polypoidal Lesions in Patients With Polypoidal Choroidal Vasculopathy Using Swept-Source Optical Coherence Tomographic Angiography

Qiyu Bo et al.

JAMA OPHTHALMOLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

HTRA1 synergizes with oxidized phospholipids in promoting inflammation and macrophage infiltration essential for ocular VEGF expression

Zhigang Lu et al.

PLOS ONE (2019)

添加到收藏夹

Article Ophthalmology

Choroidal morphology and short-term outcomes of combination photodynamic therapy in polypoidal choroidal vasculopathy

Jiwon Baek et al.

EYE (2019)

添加到收藏夹

Article Ophthalmology

Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen FLUID Study 24-Month Results

Robyn H. Guymer et al.

OPHTHALMOLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Associations of systemic, serum lipid and lipoprotein metabolic pathway gene variations with polypoidal choroidal vasculopathy in China

Ningda Xu et al.

PLOS ONE (2019)

添加到收藏夹

Article Ophthalmology

Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy: Two-Year Results of the Aflibercept in Polypoidal Choroidal Vasculopathy Study

Tien Yin Wong et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2019)

添加到收藏夹

Article Ophthalmology

The Evolution of Fibrosis and Atrophy and Their Relationship with Visual Outcomes in Asian Persons with Neovascular Age-Related Macular Degeneration

Chui Ming Gemmy Cheung et al.

OPHTHALMOLOGY RETINA (2019)

添加到收藏夹

Article Ophthalmology

CHOROIDAL VASCULAR HYPERPERMEABILITY AS A PREDICTOR OF TREATMENT RESPONSE FOR POLYPOIDAL CHOROIDAL VASCULOPATHY

Yasuo Yanagi et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2018)

添加到收藏夹

Article Ophthalmology

COMPARISON OF OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHIC CHANGES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ALONE OR IN COMBINATION WITH PHOTODYNAMIC THERAPY IN POLYPOIDAL CHOROIDAL VASCULOPATHY

Kelvin Yi Chong Teo et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2018)

添加到收藏夹

Review Ophthalmology

PREVALENCE OF POLYPOIDAL CHOROIDAL VASCULOPATHY IN WHITE PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION Systematic Review and Meta-Analysis

Thomas D. Lorentzen et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2018)

添加到收藏夹

Review Ophthalmology

Polypoidal Choroidal Vasculopathy Definition, Pathogenesis, Diagnosis, and Management

Chui Ming Gemmy Cheung et al.

OPHTHALMOLOGY (2018)

添加到收藏夹

Article Ophthalmology

Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials

Ebenezer Daniel et al.

OPHTHALMOLOGY (2018)

添加到收藏夹

Article Ophthalmology

Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study A Randomized Clinical Trial

Won Ki Lee et al.

JAMA OPHTHALMOLOGY (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Use of Vascular Endothelial Growth Factor Inhibitors and Complementary Treatment Options in Polypoidal Choroidal Vasculopathy: A Subtype of Neovascular Age-Related Macular Degeneration

Kelvin Yi Chong Teo et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

添加到收藏夹

Article Ophthalmology

Prevalence and Risk Factors for Polypoidal Choroidal Vasculopathy in a General Japanese Population: The Hisayama Study

Kohta Fujiwara et al.

SEMINARS IN OPHTHALMOLOGY (2018)

添加到收藏夹

Article Ophthalmology

One-year outcomes of a treat-and-extend regimen of intravitreal aflibercept for polypoidal choroidal vasculopathy

Mio Hosokawa et al.

JAPANESE JOURNAL OF OPHTHALMOLOGY (2017)

添加到收藏夹

Article Ophthalmology

Submacular hemorrhage and grape-like polyp clusters: factors associated with reactivation of the lesion in polypoidal choroidal vasculopathy

J. H. Kim et al.

EYE (2017)

添加到收藏夹

Article Ophthalmology

CHARACTERIZATION AND DIFFERENTIATION OF POLYPOIDAL CHOROIDAL VASCULOPATHY USING SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY

Chui Ming Gemmy Cheung et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2017)

添加到收藏夹

Article Ophthalmology

Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy A Randomized Clinical Trial

Adrian Koh et al.

JAMA OPHTHALMOLOGY (2017)

添加到收藏夹

Article Ophthalmology

Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy

Hyesun Kim et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2016)

添加到收藏夹

Article Ophthalmology

Incidence Rate of Massive Submacular Hemorrhage and its Risk Factors in Polypoidal Choroidal Vasculopathy

Joon Hee Cho et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)

添加到收藏夹

Article Ophthalmology

Optical coherence tomography angiography characteristics of polypoidal choroidal vasculopathy

Mayer Srour et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2016)

添加到收藏夹

Article Ophthalmology

Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials

Sumit Sharma et al.

OPHTHALMOLOGY (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Analysis of the Serum Lipid Profile in Polypoidal Choroidal Vasculopathy

Miaoling Li et al.

SCIENTIFIC REPORTS (2016)

添加到收藏夹

Letter Ophthalmology

Re: Oishi et al.: LAPTOP study: a 24-month trial of verteporfin versus ranibizumab for polypoidal choroidal vasculopathy (Ophthalmology 2014;121:1151-2)

Colin S. Tan et al.

OPHTHALMOLOGY (2015)

添加到收藏夹

Article Ophthalmology

Growth of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials

Juan E. Grunwald et al.

OPHTHALMOLOGY (2015)

添加到收藏夹

Article Ophthalmology

Prospective Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration TREX-AMD 1-Year Results

Charles C. Wykoff et al.

OPHTHALMOLOGY (2015)

添加到收藏夹

Article Ophthalmology

INITIAL VERSUS DELAYED PHOTODYNAMIC THERAPY IN COMBINATION WITH RANIBIZUMAB FOR TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY The Fujisan Study

Fumi Gomi et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2015)

添加到收藏夹

Article Ophthalmology

Polypoidal Choroidal Vasculopathy Exudation and Hemorrhage: Results of Monthly Ranibizumab Therapy at One Year

Gregg T. Kokame et al.

OPHTHALMOLOGICA (2014)

添加到收藏夹

Article Ophthalmology

Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials

Juan E. Grunwald et al.

OPHTHALMOLOGY (2014)

添加到收藏夹

Article Ophthalmology

Genes in the High-Density Lipoprotein Metabolic Pathway in Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy

Ke Liu et al.

OPHTHALMOLOGY (2014)

添加到收藏夹

Article Ophthalmology

Angiographic Features of Transgenic Mice With Increased Expression of Human Serine Protease HTRA1 in Retinal Pigment Epithelium

Sandeep Kumar et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)

添加到收藏夹

Article Ophthalmology

Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types

Akiyuki Kawamura et al.

ACTA OPHTHALMOLOGICA (2013)

添加到收藏夹

Article Ophthalmology

Comparison of the Effect of Ranibizumab and Verteporfin for Polypoidal Choroidal Vasculopathy: 12-Month LAPTOP Study Results

Akio Oishi et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2013)

添加到收藏夹

Article Ophthalmology

Relationship Between Clinical Characteristics of Polypoidal Choroidal Vasculopathy and Choroidal Vascular Hyperpermeability

Hideki Koizumi et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2013)

添加到收藏夹

Article Ophthalmology

PACHYCHOROID PIGMENT EPITHELIOPATHY

David J. Warrow et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)

添加到收藏夹

Article Ophthalmology

Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab

Shozo Sonoda et al.

BMC OPHTHALMOLOGY (2013)

添加到收藏夹

Article Medicine, General & Internal

Age-related macular degeneration

Laurence S. Lim et al.

LANCET (2012)

添加到收藏夹

Article Ophthalmology

EVEREST STUDY Efficacy and Safety of Verteporfin Photodynamic Therapy in Combination with Ranibizumab or Alone Versus Ranibizumab Monotherapy in Patients with Symptomatic Macular Polypoidal Choroidal Vasculopathy

Adrian Koh et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)

添加到收藏夹

Article Ophthalmology

Subfoveal Retinal and Choroidal Thickness After Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

Ichiro Maruko et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2011)

添加到收藏夹

Article Multidisciplinary Sciences

Increased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice

Alex Jones et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

添加到收藏夹

Article Ophthalmology

Efficacy of Intravitreal Bevacizumab Combined With Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

Fumi Gomi et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)

添加到收藏夹

Review Medicine, General & Internal

Medical progress: Age-related macular degeneration

Rama D. Jager et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

添加到收藏夹

Article Ophthalmology

Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy - One-year results of a prospective case series

WM Chan et al.

OPHTHALMOLOGY (2004)

添加到收藏夹

Article Ophthalmology

Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula

SC Lee et al.

OPHTHALMOLOGICA (2004)

添加到收藏夹

Review Ophthalmology

Polypoidal choroidal vasculopathy

AP Ciardella et al.

SURVEY OF OPHTHALMOLOGY (2004)

添加到收藏夹

Article Ophthalmology

Photodynamic therapy of polypoidal choroidal vasculopathy

AH Rogers et al.

OPHTHALMIC SURGERY LASERS & IMAGING (2003)

添加到收藏夹

Article Ophthalmology

Treatment of polypoidal choroidal vasculopathy with photodynamic therapy

RF Spaide et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2002)

添加到收藏夹

Article Ophthalmology

Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin

M Quaranta et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.